Journal of Experimental & Clinical Cancer Research · 2019 · 51 citations · 26 references
MedicineCell BiologyOncologyGene ExpressionMolecular OncologyStem Cell BiologyCancer Stem Cell BiologyCancer Stem CellsSignal Transduction In CancerStem Cell Signaling PathwaysCancer Stem Cell BiomarkersCancer Stem Cell Signaling PathwaysCanonical Wnt Beta-catenin PathwayDual-luciferase AssaysImmunofluorescence StainingLuciferase Reporter AssaysSelf-renewalSphere Formation Assays
BACKGROUND: Acute myeloid leukemia (AML) is initiated and maintained by a unique, small subset of leukemia stem cells (LSCs). LSCs are characterized by unrestricted self-renewal and contribute to the malignancy of leukemia. Aberrant protein fucosylation is associated with AML progression. However, it is still less understood that the miR-29b/Sp1/FUT4 crosstalk involved in the fucosylation-mediated LSCs malignancy in AML. METHODS: AML cell lines were sorted by magnetic microbeads to obtain the CD34 + CD38- sub-population. The key biomarkers for LSCs were identified by flow cytometry. Fucosyltransferase genes were screened by qRT-PCR, and FUT4 was focused. Effect of FUT4 on LSCs malignancy was determined by CCK8 assay, sphere formation assay, immunofluorescence staining, apoptosis and in vivo xenografts experiments. The linkage of FUT4 promoter and Sp1 was confirmed by dual-luciferase reporter gene assay. ChIP-PCR assay was used to show the directly binding of Sp1 and FUT4 promoter. Activity of Wnt//β-catenin pathway was determined by western blot. Overall survival curves were diagrammed by Kaplan-Meier analysis. RESULTS: Here, the expressional profiles of 11 fucosyltransferase genes were different comparing LSCs and non-LSCs of KG-1a and MOLM13 cells, whereas CD34 + CD38- cells exhibited higher expression of FUT4. Functionally, alteration of FUT4 in CD34 + CD38- cells modulated LSCs malignant behaviors both in vitro and in vivo. Transcriptional inhibitor actinomycin D (Act D) or translational inhibitor cycloheximide (CHX) prevented LSCs progression, and Sp1 was identified as the efficient regulator of FUT4 transcription. Moreover, miR-29b directly affected the binding of Sp1 and FUT4 promoter region, which further mediated LSCs proliferation, apoptosis and drug-resistance through fucosylated-CD44 via activation of Wnt/β-catenin pathway. Clinically, Sp1 and FUT4 were up-regulated and positively correlated with poor overall survival of AML patients. CONCLUSION: These data indicated that miR-29b/Sp1/FUT4 axis promoted the malignant behaviors of LSCs by regulating fucosylated CD44 via Wnt/β-catenin pathway. Identifying LSCs surface markers and targeting LSCs were important for the development of potential therapies in AML.
26
George A. Calin, Calin Dan Dumitru, Masayoshi Shimizu et al. · Proceedings of the National Academy of Sciences · 2002 · 5K citations · Full text
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Tsvee Lapidot, Christian Sirard, Josef Vormoor et al. · Nature · 1994 · 4.7K citations
Medicine, Cell Biology, Hematology +14
Targeting of CD44 eradicates human acute myeloid leukemic stem cells
Liqing Jin, Kristin J. Hope, Qiongli Zhai et al. · Nature Medicine · 2006 · 1.2K citations
Medicine, Hematology, Oncology +10
The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML
Andrei V. Krivtsov, Amit Sinha, Trista E. North et al. · Science · 2010 · 757 citations
Medicine, Cell Biology, Oncology +17
MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia
Ramiro Garzon, Stefano Volinia, Chang–Gong Liu et al. · Blood · 2008 · 634 citations · Full text